Guardian Historical Income Statement
| GRDN Stock | 23.88 0.43 1.77% |
Historical analysis of Guardian Pharmacy income statement accounts such as Total Revenue of 957.9 M or Gross Profit of 193.2 M can show how well Guardian Pharmacy Services, performed in making a profits. Evaluating Guardian Pharmacy income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Guardian Pharmacy's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Guardian Pharmacy latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guardian Pharmacy is a good buy for the upcoming year.
Guardian |
About Guardian Income Statement Analysis
Guardian Pharmacy Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Guardian Pharmacy shareholders. The income statement also shows Guardian investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Guardian Pharmacy Income Statement Chart
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Total Revenue
Total revenue comprises all receipts Guardian Pharmacy generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Guardian Pharmacy Services, minus its cost of goods sold. It is profit before Guardian Pharmacy operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Operating Income
Operating Income is the amount of profit realized from Guardian Pharmacy operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Guardian Pharmacy Services, is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Guardian Pharmacy financial statement analysis. It represents the amount of money remaining after all of Guardian Pharmacy Services, operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Guardian Pharmacy's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Guardian Pharmacy current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At this time, Guardian Pharmacy's Operating Income is very stable compared to the past year. As of the 11th of December 2024, Net Income From Continuing Ops is likely to grow to about 40 M, while Net Interest Income is likely to drop (3 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 161.3M | 185.9M | 208.3M | 193.2M | Total Revenue | 792.1M | 908.9M | 1.0B | 957.9M |
Guardian Pharmacy income statement Correlations
Click cells to compare fundamentals
Guardian Pharmacy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
Moving against Guardian Stock
| 0.82 | CCM | Concord Medical Services | PairCorr |
| 0.69 | TOI | Oncology Institute | PairCorr |
| 0.5 | HCA | HCA Holdings | PairCorr |
| 0.44 | INNV | InnovAge Holding Corp | PairCorr |
| 0.39 | CHE | Chemed Corp | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.